Intrepid Family Office Portfolio holdings
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
+$18.2M |
| 2 |
PPLT
abrdn Physical Platinum Shares ETF
PPLT
|
+$4.89M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$4.43M |
| 4 |
abrdn Physical Silver Shares ETF
SIVR
|
+$1.6M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.58M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$7.03M |
| 2 |
Shell
SHEL
|
+$1.68M |
| 3 |
Pfizer
PFE
|
+$1.65M |
| 4 |
NXP Semiconductors
NXPI
|
+$977K |
| 5 |
Medtronic
MDT
|
+$848K |
Sector Composition
| 1 | Technology | 5.72% |
| 2 | Energy | 4.33% |
| 3 | Financials | 3.98% |
| 4 | Healthcare | 3.53% |
| 5 | Materials | 2.22% |
Similar funds
Intrepid Family Office's Q2 2025 Portfolio in Review
As of Q2 2025, Intrepid Family Office held 43 positions worth $122M, up 72% from $71.1M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Intrepid Family Office deployed $44.3M of net new capital in Q2 2025, opening 12 new positions and adding to 8 existing holdings. Its largest new stake was SPDR Gold Trust: 60,000 shares worth $18.3M.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 7.8% a quarter earlier, followed by Energy and Financials.
On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $7.03M trimmed.
- Intrepid Family Office's largest Q2 2025 buy was SPDR Gold Trust: 60,000 shares worth $18.3M.
- Intrepid Family Office added most to abrdn Physical Silver Shares ETF in Q2 2025, an estimated $1.6M increase.
- Intrepid Family Office's biggest Q2 2025 reduction was Vanguard Total Stock Market ETF, cutting an estimated $7.03M.
- Intrepid Family Office fully exited Pfizer in Q2 2025, selling an estimated $1.65M.
- Intrepid Family Office's ten largest holdings make up 68% of its $122M portfolio in Q2 2025.
- Intrepid Family Office opened 12 new positions and closed 3 in Q2 2025.
- Intrepid Family Office's portfolio value rose 72% quarter-over-quarter to $122M.
Based on Intrepid Family Office's 13F filing for Q2 2025, filed 14 Aug 2025.